Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DHC3L2
|
|||
| Drug Name |
mRNA-1189
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Epstein barr virus infection [ICD-11: 1C80; ICD-9: 75] | Phase 1 | [1] | |
| Company |
Moderna
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05164094) A Phase 1, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 12- to 30-Year-Old Healthy Adolescents and Adults. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.